Dr. Hönle AG (
ETR:HNL -
Get Free Report)'s stock price traded up 0.2% during trading on Thursday . The stock traded as high as €9.32 and last traded at €9.30. 1,370 shares traded hands during mid-day trading, The stock had previously closed at €9.28.
Dr. Hönle Price Performance
The business's 50-day simple moving average is €9.07 and its two-hundred day simple moving average is €8.22. The stock has a market cap of $55.42 million, a price-to-earnings ratio of -4.18, a price-to-earnings-growth ratio of -0.39 and a beta of 1.45. The company has a debt-to-equity ratio of 63.28, a current ratio of 1.77 and a quick ratio of 0.85.
About Dr. Hönle
(
Get Free Report)
Dr. Hönle AG engages in the supply of industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, automotive, optics and opto-electronics, medical technology, and glass processing. The Equipment & Systems segment engages in the provision of solutions used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and solar simulation.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dr. Hönle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Hönle wasn't on the list.
While Dr. Hönle currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
